Please take a moment to take action on this issue here: http://capwiz.com/norml2/issues/alert/?alertid=15006066
President Barack Obama has nominated Michele Leonhart to head the U.S. Drug Enforcement Administration. NORML is asking you to contact your Senator today and urge him or her to reject this nomination.
As interim director, Ms. Leonhart has obstructed efforts to end the destructive conflict between federal and state medical marijuana laws while overseeing federal raids and arrests in disregard of state law – contrary to the present policy of this administration.
Furthermore, she has blocked scientific research on medical marijuana, in disregard of this administration’s pledge to let science, rather than ideology, guide public policy.
In particular, Ms. Leonhart has neglected to reply to an eight-year old petition to reschedule marijuana for medical use, which is supported by NORML and was called for by the AMA and a growing number of states and federal judges.
She has further denied the application of the University of Massachusetts to establish a research facility for FDA development of marijuana, overruling the recommendation of the DEA’s own administrative law judge that this was not in the public interest.
Ms. Leonhart has incomprehensibly called the rising death toll of civilians attributable to the U.S./Mexican drug war “a signpost of the success” of her agency’s policies.
Ms. Leonhart’s actions and ambitions are incompatible with common sense marijuana law reform and the stated policies of this administration. Please urge Congress to reject this nomination. For your convenience, a prewritten letter will be e-mailed to your member of the U.S. Senate when you visit NORML’s ‘Take Action’ Center here:
http://capwiz.com/norml2/issues/alert/?alertid=15006066
Thank you for assisting NORML’s federal law reform efforts.
